Valuation: Venus Remedies Limited

Capitalization 1.05TCr 12Cr 9.97Cr 9.28Cr 8.64Cr 16Cr 17Cr 106.73Cr 42Cr 500.39Cr 43Cr 42Cr 1.83TCr P/E ratio 2024
15.3x
P/E ratio 2025 8.84x
Enterprise value 894.44Cr 9.86Cr 8.5Cr 7.91Cr 7.37Cr 14Cr 15Cr 91Cr 36Cr 426.65Cr 37Cr 36Cr 1.56TCr EV / Sales 2024
0.65x
EV / Sales 2025 0.38x
Free-Float
50.95%
Yield 2024 *
-
Yield 2025 -
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.94%
1 week+7.97%
Current month+2.32%
1 month+3.41%
3 months+73.15%
6 months+42.39%
Current year+2.32%
More quotes
1 week 699.9
Extreme 699.9
816.35
1 month 682
Extreme 682
848.9
Current year 682
Extreme 682
816.35
1 year 272.2
Extreme 272.2
848.9
3 years 145
Extreme 145
848.9
5 years 145
Extreme 145
848.9
10 years 19.5
Extreme 19.5
848.9
More quotes
Manager TitleAgeSince
Chief Executive Officer 48 01/05/2007
Chief Executive Officer 61 11/12/2009
Chief Administrative Officer - 01/01/1999
Director TitleAgeSince
Director/Board Member 48 01/05/2007
Chairman 61 11/12/2009
Director/Board Member 57 09/04/2015
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.94%+7.97%+161.99%+361.65% 12Cr
+0.53%-2.37%+43.09%+194.99% 93TCr
-0.41%+6.98%+48.72%+28.81% 53TCr
-0.31%-2.60%+24.94%+43.67% 38TCr
+0.93%+2.38%+31.46%+17.91% 37TCr
+0.19%-1.15%+28.47%+21.37% 29TCr
+0.98%+1.37%+29.42%+36.42% 28TCr
-1.93%-1.54%+11.14%+0.04% 27TCr
+6.49%+1.95%-32.44%-19.12% 27TCr
+0.12%+1.32%+21.43%+24.97% 18TCr
Average +0.75%+1.43%+36.82%+71.07% 34.91TCr
Weighted average by Cap. +0.59%+0.50%+29.05%+67.41%
See all sector performances

Financials

2024 2025
Net sales 601.45Cr 6.63Cr 5.71Cr 5.32Cr 4.95Cr 9.22Cr 9.92Cr 61Cr 24Cr 286.89Cr 25Cr 24Cr 1.05TCr 647.89Cr 7.14Cr 6.16Cr 5.73Cr 5.34Cr 9.93Cr 11Cr 66Cr 26Cr 309.04Cr 27Cr 26Cr 1.13TCr
Net income 28Cr 31.4L 27.07L 25.2L 23.46L 43.68L 47L 2.9Cr 1.14Cr 14Cr 1.18Cr 1.15Cr 50Cr 45Cr 49.94L 43.06L 40.08L 37.31L 69.48L 74.75L 4.61Cr 1.82Cr 22Cr 1.87Cr 1.83Cr 79Cr
Net Debt -42Cr -46.82L -40.36L -37.57L -34.98L -65.13L -70.07L -4.32Cr -1.7Cr -20Cr -1.76Cr -1.72Cr -74Cr -154.6Cr -1.7Cr -1.47Cr -1.37Cr -1.27Cr -2.37Cr -2.55Cr -16Cr -6.2Cr -74Cr -6.39Cr -6.26Cr -269.28Cr
More financial data * Estimated data
Logo Venus Remedies Limited
Venus Remedies Limited is a research-driven pharmaceutical company. The Company is a global injectable manufacturer. It manufactures products catering to critical care segments such as antimicrobial resistance, anti-cancer, Anti-infective, Neurology, Skin and Wound Care, and Pain Management. With a diverse portfolio of products, the Company is dedicated to revolutionizing patient care through its specialized therapeutic segments such as anti-infective (antibiotics), oncology, neurology, pain management, and skin & wound care. The Company operates only in one business segment: Pharmaceutical Formulation and is engaged in manufacturing and trading of medicines. Its focus therapy areas include medicine, surgery, neuro and orthopedics. The Company’s brands include Potentox, Vancoplus Combi, Tobracef, Supime, Zydotum, Neurotol, Trois, Septiloc, Mucomelt, and others. It has three manufacturing facilities: Panchkula and Baddi in India and Werne in Germany.
Employees
1,298
More about the company
Date Price Change Volume
16/26/16 784.80 +0.94% 2,367
14/26/14 777.50 +4.44% 6,001
13/26/13 744.45 +5.00% 1,677
12/26/12 709.00 -2.46% 754

Delayed Quote Bombay S.E., January 16, 2026 at 03:30 pm IST

More quotes
  1. Stock Market
  2. Equities
  3. 526953 Stock